Stockwinners Market Radar for October 11, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:10 EDT S&P announces changes to S&P SmallCap 600 index - S&P Dow Jones Indices will make the following changes in the S&P SmallCap 600: NMI Holdings (NMIH) will replace SciClone Pharmaceuticals (SCLN) effective prior to the open of trading on Monday, October 16. GL Capital Management is acquiring SciClone Pharmaceuticals in a deal expected to be completed on or about that date pending final closing conditions. Axcelis Technologies (ACLS) will replace Landauer (LDR) effective prior to the open of trading on Thursday, October 19. S&P 500 constituent Fortive (FTV) is acquiring Landauer in a deal expected to be completed soon pending final closing conditions.

17:28 EDT On The Fly: After Hours Movers - HIGHER: Ardelyx (ARDX), up 33.3% after its tenapanor study hit its primary and secondary endpoints... Babcock & Wilcox (BW), up 9.6% after VIEX Capital Advisors reported a 6.4% stake in the company, saying the shares are undervalued... Sigma Designs (SIGM), up 3.8% after it announced major restructuring actions, including cutting 200-250 positions worldwide... XL Group (XL), up 3.2% after it said it sees net losses of $1.33B related to third quarter natural catastrophes... Herbalife (HLF), up 0.9% after Carl Icahn raised his firm's stake in the company to 26.2% due to the company's self tender offer. DOWN AFTER EARNINGS: Blackhawk (HAWK), down 7.2%. ALSO LOWER: J.Jill (JILL), down 37.6% after it cut its Q3 guidance... Protagonist Therapeutics (PTGX), down 11.9% after it filed to sell common stock... NanoString (NSTG), down 9.8% after it reported lower than expected preliminary revenue for Q3... Kandi Technologies (KNDI), down 5.5% after it filed a $300M mixed securities shelf... Juniper Networks (JNPR), down 3% after it lowered its Q3 guidance.

17:20 EDT Axcelis to replace Landauer in S&P 600 at open on 10/19 - S&P 500 constituent Fortive (FTV) is acquiring Landauer (LDR) in a deal expected to be completed soon pending final closing conditions.

17:18 EDT Axcelis to replace Landauer in S&P 600 at open on 10/19 - S&P 500 constituent Fortive (FTV) is acquiring Landauer (LDR) in a deal expected to be completed soon pending final closing conditions.

17:17 EDT NMI Holdings to replace SciClone in S&P 600 at open on 10/16 - GL Capital Management is acquiring SciClone Pharmaceuticals in a deal expected to be completed on or about that date pending final closing conditions.

17:06 EDT Tanzanian Royalty reports no plan for nationalization of Tanzania's mines - Tanzanian Royalty reports that according to a Tanzanian official spokesperson that new laws in Tanzania are not a move toward nationalization of mines. The company is not affected by new laws and regulations in Tanzania and already complies. Acting CEO Jeffrey Duval stated, "The company shared with Tanzania 45% of the asset and earnings of the Buckreef Project, for which the NI 43-101 revealed 1,064,000 ounces of gold is available to be mined at that property. This Joint Venture between the company and Tanzanian - STAMICO - was undertaken long before Tanzania sought fair treatment. (..) The company will prove that even a 45% share with the country will result in a significant reward for Tanzania and thecCompany".

17:04 EDT Integrated Core Strategies reports 5.3% passive stake in Oasis Petroleum

17:02 EDT First Tennessee Bank acquires operations, certain assets of PMC - First Tennessee Bank National Association, the regional bank of First Horizon National, has acquired the operations and certain assets of Professional Mortgage Company, or PMC. Financial terms were not disclosed.

16:56 EDT Kemper receives favorable ruling in confidential arbitration proceeding - Kemper Corporation announced that its subsidiary, Kemper Corporate Services, Inc., has received a favorable ruling in a confidential arbitration proceeding against a software vendor and has been awarded $84.3M plus interest. In October 2015, Kemper Corporate Services, Inc. filed a demand for arbitration with the American Arbitration Association, claiming that the vendor had breached the terms of a master software license and services agreement and related agreements by failing, among other things, to timely produce and deliver certain software to Kemper. The vendor denied Kemper's claims and filed a counterclaim. On October 2, 2017, the arbitrator issued a Partial Final Award in favor of Kemper. Pursuant to the material portions of the Partial Final Award: Kemper's claim that the vendor had breached the Agreements was granted; the vendor's counterclaim and affirmative defenses were denied; Kemper was awarded direct damages of $84.3M; and Kemper is entitled to pre-judgment interest in an amount to be calculated at a rate of 9%. Under the award, Kemper is also entitled to submit a petition seeking an award of certain costs and expenses of the arbitration.

16:47 EDT Markel sees Q3 pre-tax underwriting losses of $503M from hurricanes, earthquake - Markel Corporation announced that it expects to report third quarter pre-tax underwriting losses of $503M, net of reinstatement premiums, from Hurricanes Harvey, Irma and Maria as well as the Mexico City earthquakes. The company's estimate for the hurricane and earthquake losses is based on claims received to date and detailed policy level reviews, industry loss estimates, output from both industry and proprietary models as well as a review of in-force contracts. The company's estimate is preliminary and dependent on broad assumptions about coverage, liability and reinsurance. Accordingly, the company's actual net losses from these events may differ materially from this estimate.

16:43 EDT Salisbury Bancorp CFO Donald White to resign, effective October 20 - Salisbury Bancorp announced that Donald White will resign as Executive Vice President and CFO of the company and the bank effective October 20 to pursue another career opportunity. White has served as Executive Vice President and CFO since April 2013. White's resignation is not the result of any disagreement with the company or the bank on any matter relating to operations, policies, or practices.

16:32 EDT Columbia Property buys two Chelsea office proporties from New York REIT - Columbia Property (CXP) has purchased two fully leased Class-A office properties in New York's Chelsea submarket from New York REIT (NYRT) for $514M. The acquisition encompasses 245-249 West 17th Street, two adjoining office buildings collectively comprising 281,294 square feet, and 218 West 18th Street, a 165,670-square-foot office building. With this acquisition, Columbia's presence in New York has increased to seven Class-A properties comprising a total of 2.6 million square feet, which together represent 44% of Columbia's overall portfolio based on gross real estate assets.

16:31 EDT Ardelyx trading resumes

16:30 EDT Trevena trading resumes

16:21 EDT Blackhawk down 5% to $42.00 following mixed Q3 results

16:18 EDT XL Group sees net losses of $1.33B relating to Harvey, Irma, Maria - XL Group announced its preliminary estimate of net losses of approximately $1.33B relating to Hurricanes Harvey, Irma and Maria. For the third quarter of 2017, total catastrophe losses including smaller loss events are preliminarily estimated at approximately $1.48B. These preliminary estimates are pre-tax and net of reinsurance, reinstatement and adjustment premiums and redeemable non-controlling interest. On an after-tax basis, the preliminary estimate of total catastrophe net losses for the quarter is approximately $1.35B. The company's preliminary estimates are based on a combination of catastrophe modeling, exposure analysis and preliminary ground-up notifications and are consistent with private insured market loss estimates for Hurricanes Harvey, Irma and Maria in the range of $75B-$90B. Hurricanes Harvey, Irma and Maria each contributed approximately 25%, 40% and 25%, respectively, to the company loss estimates, with 10% related to all other events in the quarter, most notably the Mexican earthquakes and Typhoon Hato. The estimated losses are approximately evenly split between the company's Insurance and Reinsurance segments. Following these events and meaningful reinsurance recoveries this quarter, the company continues to have significant catastrophe reinsurance protections remaining for 2017 and 2018, including catastrophe bond protections, some of which extend through 2019.

16:15 EDT Waddell & Reed reports preliminary September AUM $80.9B - Waddell & Reed Financial reported preliminary assets under management of $80.9B for the month ended September 30, 2017, compared to $80.3B on August 31, 2017.

16:10 EDT Ardelyx trading to resume at 4:30 pm ET - Ardelyx trading is set to resume at 4:30 pm ET, with quotation scheduled to resume at 4:25 pm ET, according to Nasdaq.

16:06 EDT Trevena trading to resume at 4:30 pm ET - Trevena trading is set to resume at 4:30 pm ET, with quotation scheduled to resume at 4:25 pm ET, according to Nasdaq.

16:06 EDT ZTO Express announces increase in delivery service prices - ZTO Express announced that it is implementing certain increases in the prices of its delivery services, effective October 10. Specifically, the company will increase the last mile delivery fees payable by the parcel pick-up outlets to the delivery outlets, and the network transit fees payable by its network partners to the company for its services. The expected increase in fees varies by parcel weight and geographic location.

16:03 EDT Viking Global Investors reports 8.1% passive stake in Deciphera

16:00 EDT Trevena trading halted, news pending

15:23 EDT TransDigm dips following new Capitol Forum report - Shares of TransDigm have weakened in afternoon trading. The pullback comes after Capitol Forum said, according to Bloomberg, that the DOJ's antitrust division is probing the company's acquisition of Schroth Safety Products and Takata Protection Systems. TransDigm, which has been the subject of several prior reports from Capitol Forum, is down $2.13, or 0.8%, to $264.40 at time of writing.

15:00 EDT AbbVie says new Mavyret data to be presented at AASLD meeting - AbbVie announced that it will present new data evaluating Mavyret, its once-daily, ribavirin-free treatment for adults with chronic hepatitis C virus infection across all major genotypes at the annual meeting of the American Association for the Study of Liver Diseases, or AASLD. Sixteen AbbVie scientific abstracts have been accepted, including two oral presentations studying the use of Mavyret in patients across genotypes with compensated cirrhosis and treatment-naive patients with genotype 3 HCV. These populations have historically had limited treatment options. A third oral presentation evaluates adherence to treatment with Mavyret in the clinical development program. The Liver Meeting will take place from October 20-24.

14:41 EDT CBL & Associates CEO says will end year with 93%-94% occupancy - CBL & Associates CEO Charles Lebovitz, while speaking on CNBC, said that while the year has been "challenging," the company will end 2017 with 93%-94% occupancy.

14:21 EDT Trump says 'disgusting' press can write 'whatever they want' - President Trump, in response to a reporter's question at the White House, said it is "disgusting" that the press can write "whatever they want to write." He again rebutted NBC News' report that he sought a tenfold increase in the nation's nuclear arsenal. Comcast (CMCSA) owns NBC. Trump added that media "makes up sources" and that "there are no sources." The President says he wants the country's nuclear arsenal in "perfect" condition and "prefect" shape.

14:06 EDT Qualcomm disagrees with Taiwan Fair Trade Commission fine of $773M - Qualcomm announced that the Taiwan Fair Trade Commission has reached a decision in the TFTC's investigation, stating in a press release that certain of the company's business practices are in violation of Taiwanese competition law and imposing a fine of approximately $23.4B Taiwan dollars, or approximately $773M. Qualcomm said it "disagrees with the decision summarized in the TFTC's press release and intends to seek to stay any required behavioral measures and appeal the decision to the Taiwanese courts after receiving the TFTC's formal decision, which is expected in the next several weeks. The fine bears no rational relationship to the amount of Qualcomm's revenues or activities in Taiwan, and Qualcomm will appeal the amount of the fine and the method used to calculate it."

13:47 EDT Oculus permanently lowers price of Rift to $399 - Facebook's Oculus said that it is permanently lowering the price of the Oculus Rift to $399. Each Rift bundle comes with Touch controllers, sensors, and six free apps that give you hours of entertainment including Epic's arcade shooter, Robo Recall, and our creative tools, Medium and Quill. "Rift is here to stay with years of amazing content on the horizon," the Oculus Team said in a statement. "We can't wait for you see what else we have in store, from innovative new software features to compelling content and blockbuster IPs." Reference Link

13:43 EDT Oculus unveils standalone VR device Oculus Go - Facebook's Oculus unveiled a standalone VR device called the Oculus Go in a blog post. The device is n all-in-one, 3DOF standalone headset with an orientation-tracked controller, the company said. Oculus Go will be available globally in early 2018 and will cost $199. Oculus Go is compatible with software developed for Gear VR. Oculus Go is a standalone VR headset that comes with an orientation-tracked controller. It supports 3DOF head tracking, has best-in-class optics, a wide field of view, and fantastic ergonomics. Oculus Go has a high-resolution fast-switch LCD screen has a dramatic effect on visual clarity and reduces screen door effect. The headset is super lightweight, and the new fabric used for the facial interface is soft and breathable. Built-in speakers provide an integrated audio system that transports you straight into VR without needing headphones. Reference Link

12:49 EDT Media shares fall after Trump comment on challenging licenses - Shares of News Corp. (NWSA), Comcast (CMCSA), CBS (CBS), New York Times (NYT) and Viacom (VIAB) are dipping in afternoon trading. In a recent tweet, President Donald Trump said: "With all of the Fake News coming out of NBC and the Networks, at what point is it appropriate to challenge their License? Bad for country!" Reference Link

12:46 EDT Facebook tells CNBC 'working to get things back to normal' - A spokesperson tells CNBC that Facebook is "working to get things back to normal" following widespread reports that Facebook and Instagram are down for many users around the globe.

12:13 EDT Sears drops after Canadian counterpart announces liquidation - Sears Holdings' stock dropped after its Canadian counterpart announced it will shut down. Sears Canada, which has been operating creditor protection since June, announced on Tuesday evening that it will be applying to the Ontario Superior Court of Justice for approval to liquidate all of its remaining stores and assets. "It is expected the Court will hear the motion on October 13, 2017. Pending approval of the Court, " said the company in a statement. U.S.-based Sears Holdings owns about 10% of Sears Canada, but operates separately. FAILED RESTRUCTURING PLAN: The Canadian retailer filed for creditor protection in June and outlined a restructuring plan that included thousands of job cuts and store closings. Just last week, Sears Canada won court approval to close 11 stores and sell some businesses, and to extend creditor protection to November 7. In August, Brandon Stranzl, the executive chairman of Sears Canada stepped down in order to head up a bid to buy the company. In July, Stranzl told employees that he, along with other investors, was preparing a bid for the company. NO VIABLE TRANSACTION: Sears Canada, which has been laboring under almost a billion dollars of debt, failed to materialize a "viable" transaction. "Sears Canada received and implemented going concern transactions for various lines of business, but following exhaustive efforts, no viable transaction for the company to continue as a going concern was received. Accordingly, Sears Canada, with the recommendation of its advisors and approval of the Monitor, FTI Consulting Inc., is seeking an order to commence a liquidation that would result in a wind-down of its business following Court approval. The company deeply regrets this pending outcome and the resulting loss of jobs and store closures," said the retailer in a statement on Tuesday evening. PRICE ACTION: Shares of Sears Holdings are down 6.4% to $6.27 per share in midday trading.

12:11 EDT Pretium Resources jumps after 'positive' Q3 production update - Shares of Pretium Resources (PVG) surged after the company reported third quarter production results for the high-grade gold Brucejack Mine. WHAT'S NEW: Pretium said that, in Q3, the Brucejack Mine produced 82,203 ounces of gold. In July, at the onset of the quarter, mill feed was predominately from low-grade stockpiles and development muck and 16,882 ounces of gold were produced, the company said. As the ramp-up progressed, the mill began processing stope ore exclusively and an additional 65,321 ounces of gold were produced in the last two months of the quarter. For the quarter, mill feed grade and gold recoveries averaged 10.52 grams per tonne gold and 96.49% respectively. Mill feed grade and gold recoveries averaged 12.36 grams per tonne gold and 96.92% respectively during the last two months of the quarter as the mill transitioned to processing stope ore exclusively. The mill processed a total of 261,262 tonnes of ore for the third quarter for an average of 2,840 tonnes per day. STREET RESEARCH: Following the production update, Scotiabank upgraded the stock to Outperform from Sector Perform, citing the "positive" Q3 production results. PRICE ACTION: Near midday, shares of Pretium Resources are up 19.7% to $11.59.

11:34 EDT General Motors reports China September sales up 6.6% - General Motors and its joint ventures in China achieved their highest September sales ever, with deliveries rising 6.6% on an annual basis to 366,305 vehicles, the company announced. "In the first nine months of 2017, GM and its joint ventures in China delivered a record 2,748,139 vehicles," GM noted.

11:26 EDT Kroger clarifies on convenience store business annual sales - In a press release issued earlier today, Kroger said its convenience store business generated revenue of $1.4B in 2016. In a clarifying follow-up press release, Kroger stated: "This figure only reflects inside sales. Including fuel, Kroger's convenience store business generated $4B in total sales last year." Kroger has announced its intention to explore strategic alternatives for its convenience store business, including a potential sale, as part of its "Restock Kroger" plan, as announced earlier this morning.

11:22 EDT Seneca Foods trading halted, volatility trading pause

11:02 EDT Tenet agrees to sell MacNeal Hospital to Loyola Medicine - Tenet Healthcare Corporation announced today that it has reached a definitive agreement with Loyola Medicine, an affiliate of Trinity Health, under which Loyola will purchase MacNeal Hospital as well as other operations affiliated with the hospital. The affiliated operations include local Tenet-owned physician practices; the Chicago Health System, an independent practice association of nearly 1,000 physicians; and the associated CHS accountable care organization. Under the terms of the agreement, MacNeal and these related operations will be added to the Loyola Medicine regional health system, which serves the west, south and southwest suburbs of Chicago. The transaction is expected to be completed in 1Q18, subject to regulatory approvals and customary closing conditions.

10:52 EDT Delta says hasn't seen material decline in demand for travel to Las Vegas - Says hasn't seen material decline in demand for travel to Las Vegas following mass shooting.

10:46 EDT Coach calls name change to 'Tapestry' signal of 'evolution' - Shares of Coach (COH) dropped in morning trading after the company announced it will change its name to reflect its evolution to a multibrand firm. Separately, the stock was downgraded to Neutral at Consumer Edge. INTRODUCING 'TAPESTRY': Luxury goods maker Coach announced before the open this morning that it will change its name to Tapestry Inc. to reflect its expansion to a multibrand company following the acquisitions of Stuart Weitzman in 2015 and Kate Spade earlier this year. Coach Chief Executive Victor Luis commented, "We are now at a defining moment in our corporate reinvention, having evolved from a mono-brand specialty retailer to a true house of emotional, desirable brands, all leveraging our strong operational foundation. Each of our brands has a unique proposition, fulfilling different fashion sensibilities and emotional needs within the very attractive and growing $80B global market for premium handbag and accessories, footwear and outerwear. At the same time, our brands are also built upon the shared values of optimism, inclusivity and innovation." According to Luis, "In Tapestry, we found a name that speaks to creativity, craftsmanship, authenticity and inclusivity on a shared platform and values. As such, we believe that Tapestry can grow with our portfolio and with our current brands as they extend into new categories and markets." The company, which said the name change will be effective October 31, will also change its stock symbol to "TPR". WHAT'S NOTABLE: Luis, who was appointed CEO in 2014, laid out a plan to transform Coach three years ago with a goal of increasing relevancy and improving customer perceptions. In August, Luis said Coach was at an "exciting and pivotal moment" in its journey, and that while the company was focused on driving top- and bottom-line growth, it is also committed to achieving sustainable long-term profitability "through the health of our brands." In an interview with The New York Times, Luis said he wants to send signal to rivals in the global premium fashion market that "this is a home that is not limited to any category, channel or geography." Luis did not comment on how many or what other brands he may look to add to the "tapestry." OTHER CORPORATE REBRANDS: Coach's name change to Tapestry follows other corporate rebrandings, including the 2015 restructuring of Google (GOOG, GOOGL) to Alphabet and Tribune Publishing's 2016 name change to Tronc (TRNC). DOWNGRADE: This morning, Consumer Edge analyst David Schick downgraded Coach to Neutral from Outperform and cut his price target on shares to $40 from $50. Schick's downgrade follows a recent downgrade by Piper Jaffray analyst Erinn Murphy, who said last week that the stock is likely to enter a "period of digestion" as it integrates Kate Spade. Wolfe Research analyst Adrienne Yih Tennant also downgraded the stock recently based on a deceleration in average unit retail increases and evidence of deeper promos at full-line retail. OTHERS TO WATCH: Others in the luxury accessory space trading lower include Vera Bradley (VRA) and Michael Kors (KORS). PRICE ACTION: Coach is down nearly 2% in morning trading to $39.30. Shares are up almost 12% year-to-date.

10:40 EDT Delta Air Lines says no plans right now to increase GOL investment - Says "unlikely" that pilot requirements will be lowered.

10:29 EDT CASI Pharmaceuticals jumps after chairman buys shares - The chairman of CASI Pharmaceuticals, Wei-Wu He, disclosed in a filing on Tuesday evening that he had purchased 200,000 shares of company stock at an average price of $1.83 per share on October 5 and 6. The total transaction value was $366,000. Shares of CASI Pharmaceuticals are up 67% or $1.50 to $3.71 in morning trading.

10:20 EDT Fastenal says on track for 275-300 Onsite signings in 2017 - Says sales growth accelerated in Q3. Reports year-to-date sales growth at 10.1% Says investing in infrastructure but has continued to maintain operating expense leverage. Says operating cash flow at $162.6M was a record for any third quarter. Says signed 4,771 vending devices in Q3 and saw a lower rate of device removal. Says company feels good about top-line momentum entering Q4. Repurchased $25.9M in stock in Q3. Continues to expect capital spending at $127M for 2017. Comments taken from Q3 earnings conference call.

10:13 EDT Delta: 4% nonfuel unit cost growth 'unsustainable,' sees sub-2% growth in 2018 - Delta (DAL) CEO Ed Bastian says headwinds in the quarter included multiple hurricanes and an earthquake. Says recovery from natural disasters aided by processes implemented following April storms. Says air travel "resilient." Says rebounded quickly from Hurricane Irma. Says closed its 10% investment in Air France (AFLYY) last week. Says recently made decision to align profit sharing plans. Says 2017 has been transition year on labor costs, says 4% nonfuel unit cost growth "unsustainable" and must return to sub-2% growth starting in 2018. Says in early innings of fleet transformation. Says July business yields slightly softer than expected, saw improvements in August, September and early October. Says looking to close the year with an operating margin close to 15%, mid-teens after-tax ROIC. Says 2017 shaping up to be "pretty successful transition year," third year in a row with pretax profit at or approaching $6B. Sees 2018 system capacity growth in 2%-3% range. Comments taken from the Q3 earnings conference call.

09:38 EDT Aerie jumps after FDA posts briefing documents ahead of Rhopressa meeting - The FDA has called a meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee, to be held October 13, to discuss Aerie Pharmaceuticals' Rhopressa for the proposed indication of reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. As is its standard practice, the FDA has made background material available to the public two business days before the meeting. Following the posting of the briefing documents to the FDA website, Aerie shares are up 14% to $63.20 in early trading.

09:22 EDT Kroger to explore strategic alternatives for convenience store business - Kroger announced its intention to explore strategic alternatives for its convenience store business, including a potential sale. This is the result of a review of assets that are potentially of more value outside of the company than as part of Kroger. "Our convenience stores are strong, successful and growing with the potential to grow even more," said Schlotman. "We want to look at all options to ensure this part of the business is meeting its full potential. Considering the current premium multiples for convenience stores, we feel it is our obligation as a management team to undertake this review." Kroger's convenience store business includes 784 convenience stores located across 18 states. It includes 68 franchise operations. The stores employ 11,000 associates and operate under the following banner names: Turkey Hill Minit Markets, Loaf 'N Jug, KwikShop, Tom Thumb and QuickStop. Neither supermarket fuel centers nor Turkey Hill Dairy is included in this review. Kroger's convenience store business generated revenue of $1.4B and sold 1.2B gallons of fuel in 2016. The business unit has delivered 62 consecutive quarters of identical store sales growth.

09:20 EDT Kroger: Restock Kroger plan seen generating $400M in incremental op margin - The Restock Kroger plan is expected to generate $400M in incremental operating margin by 2020. Kroger will also outline how it will prioritize its estimated $9B in capital investments to support Restock Kroger over the next three years. The company expects to generate more than $4B of free cash flow over the next three years - nearly double what was generated over the previous three years.

09:18 EDT Kroger plans to invest incremental $500M in human capital over next three years - Kroger plans to invest an incremental $500M in human capital over the next three years. This will be in addition to the company's continued efforts to rebalance pay and benefits while also focusing on certifications and performance incentives, career opportunities and training.

09:06 EDT Citius Pharmaceuticals issues letter to shareholders - Citius Pharmaceuticals mailed a letter to its shareholders with updates on recent developments, financial results, and new business opportunities. The letter highlights, among other things: the company's uplisting to Nasdaq stock exchange; positive FDA response for phase 3 trial amendments of proprietary product Mino-Lok; secured funding of over $26.8M million; the addition of South America to the company's worldwide license for Mino-Lok; completion of Phase 2a studies for Hydro-Lido, which could become the first FDA-approved product to address the estimated $500M U.S. hemorrhoid marketplace.

09:05 EDT Dynatronics consolidates West Coast distribution activities - Dynatronics announced the consolidation of its Livermore distribution facility into its Cottonwood Heights, Utah location, which will become the company's primary distribution center for the western United States. Over the last several months Dynatronics has expanded its distribution capabilities at its headquarters facility in Utah. In association with this transition, Dynatronics will be transitioning all distribution functions to Utah from its facility in Livermore, CA. The lease on the Livermore facility will expire December 2017, with no penalty to the Company. With this simplified footprint, Dynatronics expects to provide the same level of service to Western states customers at a lower cost.

09:04 EDT Amber Road selected by GEODIS to support trade compliance capabilities - Amber Road announced that GEODIS, part of SCNF Logistics, has chosen the Amber Road Export On-Demand solution to screen third-party trade partners to ensure compliance with global sanctions and embargo lists. Using the Restricted Party Screening module in Amber Road's Export On-Demand solution, GEODIS will be able to transform its screening processes, replacing numerous disparate and partial systems with a single system covering its worldwide operations. GEODIS chose the Amber Road solution in large part because it provides the most comprehensive, continually updated global coverage of more than 570 restricted party lists from government institutions worldwide. The Amber Road solution is being rolled-out in stages through the different lines of business, beginning with screening of priority transactions and partners, and expanding to include new entities. Within a few weeks of the implementation kick-off in January, key teams were already using the solution.

09:02 EDT Amazon introduces all-new Kindle Oasis featuring 7-inch, 300ppi display - Amazon announced its "most advanced Kindle e-reader ever-the all-new Kindle Oasis, featuring our largest, highest-resolution Paperwhite display yet and a thin and light ergonomic design so you can read more comfortably for hours. The all-new Kindle Oasis is the first waterproof Kindle allowing you to read in even more places, from the bath to the swimming pool. The all-new Kindle Oasis has a battery life measured in weeks, not hours-and it includes a fast-charging capability that allows it to go from no battery to fully charged in less than two hours. With Audible built in, you can listen to the world's largest library of audiobooks and easily switch between reading and listening to a professionally narrated performance on Bluetooth headphones or speakers. The all-new Kindle Oasis is available for pre-order today for only $249.99 and will start shipping October 31."

09:01 EDT Amazon launches way for teens to shop on their own, keeping parents informed - Amazon introduced a convenient way for teens 13 through 17 years old to shop on Amazon with their own login. For the first time, teens can independently use the Amazon App, allowing them to shop or stream content while still keeping their parents informed. Parents can approve all orders or set pre-approved spending limits per order - offering teens a customized level of autonomy that can change and grow as they do.

08:56 EDT BlackRock: Aladdin for wealth management has 'big future opportunity' - Says demand "significant."

08:53 EDT BlackRock expects 'significant' growth opportunities for Aladdin

08:47 EDT Immune poster demonstrates activity of anti-eotaxin-1 antibodies in animal model - Immune Pharmaceuticals announced that the results of a study investigating the therapeutic effect of oral and parenteral administration of anti-eotaxin-1 antibodies in an animal model of immune-mediated hepatitis will be presented at The Liver Meeting 2017 - the 68th Annual Meeting of the American Association for the Study of Liver Diseases taking place October 20-24, 2017 in Washington, DC. Dr. Yaron Ilan, Professor of Medicine, and Director, Department of Medicine at Hebrew University's Hadassah Hospital in Jerusalem, Israel, and an Immune Pharmaceuticals collaborator, will present the data in a poster. The poster, entitled "Oral administration of anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel personalized therapy for immune-associated liver diseases" will be presented Friday, October 20 between 12:00 and 1:30 PM ET at the "Autoimmune and Cholestatic Liver Disease" session. The study aimed to evaluate the biological activity and immunomodulatory effect of oral and parenteral administration of anti-eotaxin-1 antibodies in the concanavalin A mouse model of immune hepatitis. Anti-eotaxin-1 antibodies, administered two hours prior to the induction of hepatitis, lowered eotaxin-1 levels and prevented the development of hepatitis compared to controls.

08:42 EDT BlackRock: Market environment has improved 'considerably' over past year - Assuming no current year impact from potential future change in tax laws, BlackRock believes 31% remains reasonable projected tax run rate for Q4, though actual effective tax rate may differ. Says "very margin aware." Says the market environment has improved "considerably" over the past year, with greater political stability in Europe, consistent growth in Japan and continued economic strength in China. Say that while the world has become "much more resilient," large cash balances "remain on the sidelines." Comments taken from the Q3 earnings conference call.

08:35 EDT WellCare members' access to UNC Health Alliance expanded - WellCare announced that UNC Health Alliance's physician-led network of Health Care providers have entered into an agreement to join the health plan's provider network. Beginning in 2018, WellCare's Medicare Advantage members will have access to the UNC Health Alliance network of primary care providers and specialists; UNC hospitals; and nine affiliate hospitals and hospital systems across the state.

08:32 EDT Jamba announces hearing panel date, Nasdaq listing extension - Jamba announced the Nasdaq Stock Market granted the company's request for a hearing before the Nasdaq Hearings Panel. The hearing will take place on November 16, at which time the company will present its plan to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission. Previously, Nasdaq granted the company an extension until September 18 to file all delinquent periodic reports. The company also announced that the Panel granted the company's request to extend the automatic 15-day stay of suspension from The Nasdaq Stock Market. The stay, which allows for the continued trading of the company's common stock on Nasdaq, will continue until a final determination regarding the company's listing status is issued after the November 16 hearing. The Company fully intends to continue to take all steps necessary to regain compliance with the Rule.

08:31 EDT Goodyear Tire increases dividend on common stock 40% to 14c per share - Goodyear Tire has approved an increase in the company's quarterly common stock dividend to 14c per share from 10c, a 40% The dividend is payable December 1 to shareholders of record on November 1.

08:22 EDT MagneGas signs $500,000 consulting agreement with European partner - MagneGas announced that the company has been engaged by its European partner to provide consulting services, focused on identifying and validating additional applications of the MagneGas technology in Europe. The initial value of the contract is approximately $500,000, with an option to increase the scope of the contract to $1M. The agreement also provides MagneGas access to testing facilities, which are already approved for a range of waste streams, to determine the economic value and technical feasibility of new gasification and sterilization solutions in Europe.

08:08 EDT JetBlue: Q3 presented 'unprecedented weather challenges'

08:04 EDT MabVax Therapeutics begins enrollment in Phase 1 trial for cancer treatment - MabVax Therapeutics initiated patient enrollment at a second site in a Phase 1 clinical trial evaluating a new radioimmunotherapy product for patients with locally advanced or metastatic adenocarcinoma of the pancreas or other CA19-9 positive malignancies including colon and lung cancers. MVT-1075 combines radiotherapy with the tumor targeting specificity of the HuMab-5B1 antibody. The company's objective is now to enroll additional patients and report interim results before the end of the year.

08:04 EDT Seattle Genetics announces collaborations to evaluate SGN-LIV1A - Seattle Genetics (SGEN) announced two clinical collaboration agreements for the evaluation of SGN-LIV1A in patients with triple negative breast cancer. SGN-LIV1A is an investigational antibody-drug conjugate that targets the cell surface protein LIV-1, which is expressed on multiple solid tumors including breast, prostate, melanoma, ovarian, and cervical cancers. The ADC will be tested in combination with KEYTRUDA, an anti-PD-1 therapy marketed by Merck (MRK), in a phase 1b/2 clinical trial as first line treatment for locally advanced and metastatic TNBC. SGN-LIV1A in combination with standard chemotherapy will also be evaluated as neoadjuvant treatment in the phase 2 I-SPY 2 TRIAL for newly diagnosed Stage 2 or 3 human epidermal growth factor receptor 2 negative breast cancer, sponsored by Quantum Leap Health Care Collaborative. This cancer subgroup accounts for up to 85% of breast cancer and includes TNBC. SGN-LIV1A administered in combination with Merck's pembrolizumab will be evaluated in a phase 1b/2 clinical study in patients with locally advanced or metastatic TNBC. This single arm, open label multicenter study is anticipated to enroll up to 72 patients. Under the terms of the collaboration agreement with Merck, Seattle Genetics will hold the IND for the study and retain global development and commercialization rights to SGN-LIV1A. SGN-LIV1A followed by standard chemotherapy will be evaluated as a neoadjuvant treatment for women with newly diagnosed, locally advanced Stage 2 or 3 HER2-negative breast cancer in the I-SPY 2 TRIAL. This standing phase 2 randomized, controlled multicenter trial is anticipated to enroll up to 75 patients in the SGN-LIV1A treatment arm. With TNBC and other aggressive cancers in mind, the I-SPY 2 TRIAL was designed to rapidly screen promising experimental treatments and identify those most effective in specific patient subgroups based on molecular characteristics. The trial is a unique collaborative effort by a consortium that includes the Food and Drug Administration, industry, patient advocates, philanthropic sponsors and clinicians from 20 major U.S cancer research centers. Under the terms of the collaboration agreement, Quantum Leap is the trial sponsor and will manage the study operations. Seattle Genetics will retain global development and commercialization rights to SGN-LIV1A.

08:03 EDT Mustang Bio announces $12.8M grant to fund Phase 1 trial of MB-101 - Mustang Bio (MBIO), a Fortress Biotech (FBIO) company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell, or CAR T, technology, announced that research and development partner City of Hope has received a $12.8M grant from the California Institute for Regenerative Medicine to fund an ongoing Phase 1 study of Mustang's MB-101 for the treatment of patients with recurrent and refractory malignant glioma, including glioblastoma.

08:02 EDT Centene comments on lowered 2018 Medicare Star quality rating - Centene commented on updated Medicare Star quality ratings for the 2018 rating year published by the Centers for Medicare and Medicaid Services. The 2018 rating year will affect quality bonus payments for Medicare Advantage plans in 2019. Health Net of California's Medicare Advantage plan will move to a 3.5 Star rating from a 4.0 Star rating for 2018. The effect of this Star rating change will lower Centene's parent Star rating for the 2018 rating year from 4.0 Stars to 3.5 Stars. The reduction in the Star rating for Health Net of California is the result of a 2015 program audit. Health Net of California's underlying rating reflects 4.0 Star performance; however, CMS lowered a single measure because of a penalty associated with a plan audit in 2015, which caused a decline in the overall score to 3.5 Stars. Improvements were insufficient to compensate for the lower BAPP measure. The penalty related to the 2015 program audit will not have a continuing impact on the Star ratings in future rating years. The company intends to appeal the application of the penalty.

08:01 EDT Neenah Paper to acquire Coldenhove for about $45M - Neenah Paper announced it had signed a definitive agreement to purchase all of the outstanding equity of W.A. Sanders Coldenhove Holding B.V. Coldenhove is a specialty materials manufacturer based in the Netherlands, with a leading position in digital transfer media and other technical products. Coldenhove has annual sales of over $45M with EBITDA of approximately $6M. The company's advanced media is a critical component used in dye sublimation, a growing method of digital image transfer. The purchase price is expected to be approximately $45M, subject to final closing adjustments, and will be financed with available cash and short term borrowings. Closing is expected to occur on November 1, and is subject to customary conditions. "This acquisition adds to our technical products portfolio with products, technologies and a customer base that nicely complement our existing digital transfer business, further accelerating our participation in profitable growing markets," said John O'Donnell, CEO. "From a financial perspective, the investment provides an attractive return on capital, is immediately accretive, and will deliver mid-teen EBITDA margins in a growing market."

07:54 EDT Penske Automotive increases dividend to 33c per share - Penske Automotive has approved an increase in the cash dividend to 33c per share for Q3. The dividend is payable on December 1 to shareholders of record on November 10.

07:52 EDT Moleculin announces strategic collaboration to develop immune stimulation drug - Moleculin Biotech announced that it has entered into an agreement to collaborate with the University of Bergen to expand research on inhibition of brain metastasis by Moleculin's pre-clinical drug WP1066 and its unique ability to increase immune system response to cancer and suppression of tumor cell proliferation and survival. The company previously announced that Moleculin is working with MD Anderson in their effort to move forward with a physician sponsored IND application to study WP1066 in patients with glioblastoma and melanoma that has metastasized to the brain. That IND has been on hold pending responses to requests from the FDA. If the FDA allows the IND to proceed based on the responses provided, Moleculin anticipates this clinical trial could be ready to begin by the end of this year.

07:49 EDT U.S. Gold plans additional autumn drill program on Keystone Project, Nevada - U.S. Gold announced a planned drilling program to be conducted on the Keystone and Gold Bar North projects. This program will be comprised of nine to ten holes, approximately a total of 15,000 feet, and will be conducted under four separate BLM-approved Notices of Intent. U.S. Gold continues to move forward with a project-wide Environmental Assessment for an expanded 2018 drilling program. U.S. Gold controls 100% of the Keystone District. The company reports that quality, large gold deposit target opportunities are demonstrably emerging throughout the district, especially in areas where previous drilling has been very sparse to nonexistent. The fall drilling program, in general, provides the first drill hole tests of several identified target opportunities indicated from recently obtained detailed gravity data in combination with stream sediment, altered cobble, soil samples, and detailed geological mapping.

07:32 EDT Molina Healthcare names former Hanover Insurance exec as CEO - Shares of Molina Healthcare (MOH) are lower in premarket trading after the company, which offers Medicaid-related solutions for low-income families and individuals, named Joseph Zubretsky as its new chief executive officer. CEO APPOINTMENT: Molina Healthcare on Tuesday afternoon announced that Joseph Zubretsky will become the insurer's next president and CEO, effective November 6. Zubretsky most recently served as president and CEO of The Hanover Insurance Group (THG) and previously served nearly nine years at Aetna (AET) as the CEO of Healthagen Holdings. Commenting on the executive appointment, Molina Chairman Dale Wolf said "Joe is the right CEO to lead Molina during this transformative period. He has a track record of strong leadership across multiple businesses, both inside and outside managed care, and has first-hand experience in leading restructuring efforts at previous organizations. We are confident that, under Joe's leadership, Molina is well-positioned to realize the benefits of our transformation, build on the company's strengths, drive operational excellence, and increase shareholder value." WHAT'S NOTABLE: Zubretsky replaces chief financial officer Joseph White, who was named interim CEO in May after the company fired CEO J. Mario Molina and CFO John Molina. After reporting extremely weak second quarter earnings in August, White said the company was taking "aggressive steps" to improve its financial performance going forward. In light of the "disappointing" Q2 results, White announced that Molina was implementing a companywide restructuring plan that includes the exist of the Utah and Wisconsin ACA marketplaces and the reduction of 1,500 jobs. Molina is also reducing its presence in the Washington marketplace in 2018, it said, adding that in the remaining marketplaces, it will raise premiums by 55%. The plan is expected to reduce annualized run-rate expenses by between $300M-$400M by late 2018. "We continue to closely monitor the current political and programmatic developments pertaining to our 2018 participation in other Marketplace states, and subject to those developments, will withdraw from 2018 participation as may be necessary," Molina said at the time. OTHERS TO WATCH: Publicly traded companies in the insurance space include Aetna, Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), UnitedHealth (UNH) and WellCare (WCG). PRICE ACTION: In premarket trading, Molina Healthcare is down about 2% to $64 per share.

07:31 EDT Akamai to acquire Nominum in all-cash transaction - Akamai announced the company has entered into an agreement to acquire Nominum, a market leader in DNS and enterprise security solutions for carriers. The acquisition is intended to add complementary capabilities to Akamai's portfolio of security offerings while expanding Akamai's distribution to carriers that serve enterprise customers. The all-cash transaction is expected to close later this quarter. Nominum is a privately-funded company headquartered in Redwood City, CA. Akamai expects the acquisition to be dilutive to non-GAAP earnings in the fiscal fourth quarter and 2018 due to integration costs and the impact purchase accounting has on revenue recognition. The dilutive impact in the fiscal fourth quarter of 2017 is expected to be approximately $0.05, and approximately $0.11 for fiscal 2018. Akamai expects the acquisition to be accretive in 2019. Akamai reiterates its intention to manage the Company's EBITDA margins within its previously stated range of mid-30s while it integrates Nominum.

07:11 EDT Unisys selected by Spain's ENAIRE for corporate applications development - Unisys announced a new contract with ENAIRE, the national air navigation service provider of Spain, to provide a package of services, including corporate applications development and employee mobile enablement. Unisys will develop and maintain all corporate applications and managing service delivery to Android and iOS mobile users for connectivity to key applications and data via mobile phone or tablet. Additionally, Unisys will help ENAIRE with new development projects.

07:06 EDT Delta Air Lines CEO sees 'good momentum' after 'busiest summer travel season' - "While we faced a number of challenges this quarter, including multiple hurricanes and an earthquake in Mexico, I am proud of how Delta people responded and still delivered an outstanding performance this quarter. Having just completed the busiest summer travel season in our history, we have good momentum, a determined team and a solid pipeline of initiatives to grow earnings and margins," said CEO Ed Bastian. Delta reports Q3 passenger revenue increased $328M, including $160M from Delta's Branded Fares initiatives. Passenger unit revenues increased 1.9% on 1.6% higher capacity. Cargo revenue increased 11.5%, driven by higher volumes in freight and mail. Other revenue increased 18.4% primarily due to higher loyalty revenue and third-party refinery sales.

07:04 EDT BioTime, Processa to enter into HyStem sublicense for drug delivery - BioTime reached agreement on terms to sublicense certain HyStem rights to Processa Pharmaceuticals for the creation of a sustained-release delivery platform. HyStem is BioTime's cell and drug delivery platform. HyStem technology includes a family of unique, biocompatible hydrogels designed to effectively deliver cells or bioactive compositions for therapeutic benefit. HyStem was designed to enable the effective transfer, engraftment and metabolic support for cells and is the basis of BioTime's Renevia program. The flexible chemistry of the HyStem also allows for hydrogel optimization in the delivery of drugs and therapeutics. BioTime is actively pursuing local delivery aspects of this platform technology.

07:03 EDT QuickLogic partners with AcconSys in China - QuickLogic announced it has signed an agreement with AcconSys, an EDA tool and semiconductor intellectual property distributor in China. AcconSys will provide sales and support for QuickLogic's ArcticPro eFPGA solutions.AcconSys has a significant presence throughout the country's largest metropolitan regions, and has a proven track record in sales and strong relationships with tier-one customers. The company's application engineering teams have extensive experience in SoC, system design and integrated electronic systems.

07:02 EDT Anthem Medicare plans to achieve significant 2018 Medicare Star Ratings - Anthem announced that its Medicare Advantage health plan affiliates have improved their Medicare Star Ratings. The Centers for Medicare and Medicaid Services released their latest Star Ratings, which give health plans scores for the quality and performance of their services. Heading into 2018, more than 60% of the Medicare Advantage members in Anthem's affiliated health plans will be enrolled in plans that achieved four stars or better, with five stars being the best rating. The Star Ratings provide further confirmation that Anthem's multi-year focus on improving the quality of its Medicare offerings is delivering real benefits for members. Additionally, the company aims to further improve the Stars performance of its health plans moving into 2019. This announcement is a significant achievement, as the ratings represent the highest percentage garnered by the company and its health plan affiliates since the start of CMS' Medicare Star Ratings program. According to the 2016 Star Ratings, only 22% of members were enrolled in four-star or better plans.

06:56 EDT Ryder acquires Dallas Service Center - Ryder has completed the acquisition of all outstanding equity of Dallas Service Center, an independent truck repair facility located in Dallas, Texas. The acquisition is expected to be nominally accretive to earnings in 2017. Ryder anticipates additional earnings in future years due to synergies. Ryder intends to retain the existing workforce of approximately 50 employees.

06:51 EDT Fastenal says increased headcount by 378 during past year - "During the last twelve months, we have increased our headcount by 201 people in our in-market units and 378 people in total. Our total headcount includes 123 people related to our Mansco acquisition. The remaining increase is mostly a function of additions we have made to support customer growth in the field as well as investments in our growth drivers. We opened 5 branches and closed 36 branches in the third quarter of 2017. Additionally, two branches were converted from a public branch to a non-public location. Our branch network forms the foundation of our business strategy, and we will continue to open or close branches in 2017 as is deemed necessary to sustain and improve our network and support our growth drivers."

06:47 EDT Comstock Mining reduces debt by $1M through non-core assets sale - Comstock Mining has reduced long-term debt by almost $1M with proceeds from the sale of 53 acre-feet of water rights, and the sale of various, smaller non-mining properties in Gold Hill and Silver City, Nevada and its recently announced joint venture with Tonogold Resources. The most valuable of the remaining properties is the company's 98-acre Comstock Industrial Site located adjacent to the Silver Springs Airport. The company's Senior Secured Debenture has now been reduced to $9.9M. The company still has plans to sell non-mining assets valued at approximately $14M targeted to eliminate the remainder of its debt. The company also had approximately $2.3M in cash at September 30.

06:34 EDT BlackRock CEO: Seeing more clients looking to put money to work - Says biggest problem is money sitting on the sidelines. Says seeing growth in every product area. Larry Fink is speaking on CNBC.

06:31 EDT Gold Standard Ventures approved for listing on Toronto Stock Exchange - Gold Standard Ventures is pleased to announce that its common shares have been approved for listing on the Toronto Stock Exchange and will commence trading on the TSX at the opening of market on October 11. Concurrent with the TSX listing, the Common Shares will be de-listed from the TSX Venture Exchange. The trading symbol of the Common Shares will continue to be "GSV".

06:26 EDT Trump: Stock market has increased by $5.2T since election, a 25% increase - President Trump tweeted, "Stock Market has increased by 5.2 Trillion dollars since the election on November 8th, a 25% increase. Lowest unemployment in 16 years." Reference Link

06:16 EDT BlackRock reports Q3 AUM $5.97T, up 17% y/y, up 5% sequentially

06:03 EDT Athersys partnering with Nikon CeLL for MultiStem manufacturing in Japan - Athersys (ATHX) has entered into a manufacturing services agreement with Nikon CeLL innovation for commercial production of its stem cell therapy, MultiStem, in Japan for ischemic stroke. NCLi is a wholly-owned subsidiary of Nikon (NINOY) and provides a range of process development and manufacturing services, from pre-clinical to commercial manufacturing of cell and gene therapies. Athersys and NCLi will engage in technology transfer activities at NCLi's facility in Japan, and NCLi will begin contract manufacturing support for commercial development of the product in Japan.

05:56 EDT MannKind sees Q3 net Afrezza product revenue $1.8M-$2.2M - For the three months ended September 30, MannKind expects to report $2.6M-$3.0M of gross Afrezza product revenue and $1.8M-$2.2M of net Afrezza product revenue. MannKind estimates that as of September 30, its cash and cash equivalents were approximately $20.2M. MannKind estimates that as of September 30, the principal balance outstanding for its 9.75% Senior Convertible Notes due 2019 and 8.75% Senior Convertible Notes due 2019 issued under its facility agreement with Deerfield was $60M; its 5.75% Convertible Senior Subordinated Exchange Notes Due 2018 was $27.7M; and its borrowings under the loan arrangement with The Mann Group was $79.7M. MannKind estimates that the annual purchase requirements under the insulin supply agreement with Amphastar as of September 30 were unchanged from June 30, except for the impact of foreign currency translation. MannKind said it has not yet purchased the annual minimum required quantities of insulin for 2017 of EUR 2.7M.

05:35 EDT China Xiniya Fashion receives notice of noncompliance from NYSE - China Xiniya Fashion announced that, on September 11, the company received notification from NYSE Regulation of being below the continued listing standards of the New York Stock Exchange. The company is considered below criteria established by the NYSE because the company's average market capitalization has been less than $50M over a consecutive 30 trading-day period and its last reported shareholders' equity was less than $50M. In accordance with NYSE procedures, the company has 90 days from the receipt of the notice to submit a plan to the NYSE demonstrating how it intends to regain compliance with the NYSE's continued listing standards within 18 months. The company intends to develop and submit such a business plan within the required time frame. The NYSE staff will then evaluate the plan to determine whether the company has made a reasonable demonstration of an ability to come into conformity with the listing standard within 18 months. In the event the NYSE accepts the plan, the company will be subject to quarterly monitoring for compliance with the plan and the company's ADSs will continue to trade on the NYSE during the plan period, subject to the company's compliance with other NYSE continued listing requirements. In the event the NYSE does not accept the plan, the company will be subject to suspension by the NYSE and delisting procedures. In the event the company is delisted, the stock may continue to be traded in the Over-The-Counter market. The company's business operations, its SEC reporting requirements, and all other contractual obligations, including sales and procurement contracts, are unaffected by the notice from NYSE.

05:29 EDT Advanced Semiconductor reports Sept. revenue up 4.6% to $905M - Reports September ATM net revenue up 0.9% to $465M.

05:25 EDT Allegiant raises Q3 TRASM guidance to up 0.3%-0.7% from down 0.5% to up 1.5% - Narrows Q2 CASM guidance to 16.7%-17.1% from 16%-18%.

05:22 EDT Allegiant Travel sees Q4 Total System departures up 7%-11%, ASMs up 9%-13% - Sees Q4 Scheduled Service departures up 7%-11%, ASMs up 9%-13%.

05:20 EDT Allegiant Travel reports Sept. Scheduled Service passenger traffic down 10.3% - Reports September Scheduled Service RPM down 9.5%, ASM down 5%, and load factor down 3.9 percentage points to 78.9%. Reports September Total System passenger traffic down 9.1%, RPM down 8.4%, ASM down 2.6%, and load factor down 4.7 percentage points to 75.2%.

05:13 EDT EnerNOC awarded 50 MW demand response contract in Australia - EnerNOC announced that it has been awarded a three-year demand response contract with the Australian Renewable Energy Agency, or ARENA, and the NSW Government. Under the terms of the contract, EnerNOC will develop and operate a 50 MW demand response, or DR, resource to support system reliability in the National Electricity Market, or NEM. The dispatchable DR resource will utilise aggregated load curtailment from commercial and industrial energy users across New South Wales and Victoria to respond within 10 minutes when dispatched by the Australian Energy Market Operator, or AEMO. This new DR resource will be available for dispatch December 2017, thus ensuring it will enhance system reliability during the peak summer months.